Monsanto (MON) Takeover Noise; Exane BNP Paribas Ups View on Barclays (BCS)
Shares of Monsanto Company (NYSE:MON) soared to touch the $100.85 mark in early trade Thursday following a report by Bloomberg indicating that German firm Bayer AG (OTCMKTS:BAYRY) is exploring a potential bid to acquire the major U.S. agribusiness company.
Monsanto recently reported second quarter fiscal 2016 net sales of $4.5 billion.
MON stock is trading at $98.11, up $7.77 (or +8.60%) and 12,999,965 of its shares exchanged hands so far, a large increase in activity versus its average volume (3m) of 3,097,440
Monsanto, which provides agricultural products for farmers worldwide, has 436.84M Shares Outstanding and MON stock 52-week range is from $81.22 to $121.09 per share
Brokerage firm Exane BNP Paribas upgraded shares of Barclays PLC (NYSE:BCS) from an Underperform to a Neutral rating
Major U.K. bank Barclays posted fist quarter 2016 pretax profit of 793 million pounds.
BCS stock is exchanging hands at $9.44, up $0.04 (or +0.43%) on Thursday’s trading session
Barclays, which provides various financial products and services worldwide, has 4.97B Shares Outstanding and BCS stock one-year range is between $8.20 and $18.05 per share
Disclaimer: The disclaimer is to be read and fully understood before using our site, or joining our email list. GalaxyStocks is not a registered investment adviser. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Investors should always conduct their own due diligence with any potential investment, with independent research and other professional advice. Read full disclaimer at http://galaxystocks.com/disclaimer/